NOBOX gene variants in premature ovarian insufficiency: ethnicity-dependent insights
Authors:
- Pénélope JordanPJPénélope Jordan
- Camille VerebiCVCamille Verebi
- Sandrine PerolSPSandrine Perol
- Sarah GrottoSGSarah Grotto
- Corinne FouveautCFCorinne Fouveaut
- Sophie Christin-MaitreSCSophie Christin-Maitre
- Aude Brac de la PerrièreAPAude Brac de la Perrière
- Virginie GrouthierVGVirginie Grouthier
- Sophie Jonard-CatteauSJSophie Jonard-Catteau
- Philippe TourainePTPhilippe Touraine
- Geneviève Plu-BureauGPGeneviève Plu-Bureau
- Jean Michel DupontJDJean Michel Dupont
- 3 November 2023
- journal article
- research article
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 41 (1) , 135-146
Abstract
Purpose Premature ovarian insufficiency (POI) affects approximately 1% of women before the age of 40. Genetic contribution is a significant component of POI. The NOBOX gene was considered one of the major genetic causes of POI. However, the pathogenicity and the penetrance of NOBOX variants remain unclear. Methods We studied the whole coding region of the NOBOX gene by next generation sequencing in a cohort of 810 patients with POI, and we compared the frequency of each identified NOBOX variant to the general population taking into account the ethnicity of each individual. Results Screening of the whole coding region of the NOBOX gene allowed us to identify 35 different variants, including 5 loss-of-function variants. In total, 171 patients with POI (25%) carried out at least one NOBOX variant. Regarding missense variants, we observed a significant overrepresentation of the most frequent ones in our 810 POI patients as compared to the general, except for p.(Arg117Trp). However, taking into account the ethnic origin of the individuals, we observed no significant OR difference for p.(Arg44Leu) and p.(Arg117Trp) in African subgroup and for p.(Asp452Asn) in European subgroup. Conclusion This population study suggests that the p.(Arg44Leu) variant could be considered benign variant and that the p.(Asp452Asn) and p.(Arg117Trp) variants could be considered moderate risk pathogenic variants with probably partial and very low penetrance and/or expressivity. In contrast, p.(Gly91Trp) and p.(Gly152Arg) variants could be considered pathogenic variants with a moderate functional impact.Keywords
This publication has 19 references indexed in Scilit:
- A novel homozygous 1-bp deletion in the NOBOX gene in two Brazilian sisters with primary ovarian failureEndocrine, 2017
- A homozygousNOBOXtruncating variant causes defective transcriptional activation and leads to primary ovarian insufficiencyHuman Reproduction, 2016
- Impaired protein stability and nuclear localization ofNOBOXvariants associated with premature ovarian insufficiencyHuman Molecular Genetics, 2016
- NOBOX is a strong autosomal candidate gene in Tunisian patients with primary ovarian insufficiencyClinical Genetics, 2016
- New NOBOX Mutations Identified in a Large Cohort of Women With Primary Ovarian Insufficiency Decrease KIT-L ExpressionThe Journal of Clinical Endocrinology & Metabolism, 2015
- Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohortHuman Mutation, 2011
- Premature ovarian failure in nobox-deficient mice is caused by defects in somatic cell invasion and germ cell cyst breakdownJournal of Assisted Reproduction and Genetics, 2011
- NOBOX Homeobox Mutation Causes Premature Ovarian FailureThe American Journal of Human Genetics, 2007
- NOBOX Deficiency Disrupts Early Folliculogenesis and Oocyte-Specific Gene ExpressionScience, 2004
- Premature menopause in a multi-ethnic population study of the menopause transitionHuman Reproduction, 2003